Scholar Rock Holding Corp

-3.13 (-9.14%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.07B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$4.64 Million
Adjusted EPS-$0.82
See more estimates
10-Day MA$36.35
50-Day MA$36.25
200-Day MA$41.08
See more pivots

Scholar Rock Holding Corp Stock, NASDAQ:SRRK

301 Binney Street, 3rd floor, Cambridge, Massachusetts 02142
United States of America
Phone: +1.857.259.3860
Number of Employees: 119


Scholar Rock Holding Corp. is a biopharmaceutical company. It engages in the development and discovery of innovative medicines. The firm offers proprietary platform which designed to discover and develop monoclonal antibodies that have a high degree of specificity to achieve selective modulation of growth factor signaling. Its product candidate includes SRK-015 and SRK-181. The company was founded by Timothy A. Springer and Leonard I. Zon in October 2012 and is headquartered in Cambridge, MA.